Physicochemical drug factors
- Molecular size (Graham's Law)
- Lipid solubility
- Degree of ionisation
- Degree of protein binding
- Vascular permeability
- Regional blood flow
- Cardiac output
- The placenta is a phospholipid membrane more readily crossed by lipid-soluble molecules
- It is less selective than the BBB
- Additional factors determine the dstribution of drugs to the foetus, and the rate of equilibrium between maternal and foetal circulations
- Placental blood flow
- Materno-placental free drug concentration gradient
- The foetal circulation is of a lower pH than maternal circulation and plasma binding of drugs may differ
- Higher protein binding in the foetus will increase transfer across the placenta (as free drug concentrations are low)
- High maternal protein binding has the opposite effect
Drug transfer to the foetus
- Some drugs given in pregnancy have very late effects e.g. stilboesterol can cause ovarian cancer in teenagers if taken in pregnancy
- Thiopental cross the placenta rapidly and peak foetal levels occur within 3 mins, but there is no evidence that foetal outcome is affected
- Pethidine is highly lipid soluble and crosses the placenta easily
- It is metabolised to norpethidine, which is less lipid soluble and can accumulate in the foetus
- Peak plasma levels occur 4hrs post-IM dosing
- Half-life in foetus increased 3x due to reduced foetal clearance
- Neuromuscular blocking agents
- Non-depolarising NMBA are large, polar molecules and therefore don't cross the placenta
- Small amounts of suxamethonium cross the placenta with little foetal effect - not an issue unless sux. apnoea present
- Bupivacaine has a higher pKa than lidocaine so is more ionised at physiological pH
- It cross into the foetal circulation but becomes more ionised in the relatively acidic foetal pH
- As pH drops further (e.g. placental insufficiency) the drug becomes more ionised and may become trapped